Article info
PDFCommentary
Cost or revenue: is diabetes prevention doomed due to misalignment of incentives?
- Correspondence to Arch G Mainous 3rd; arch.mainous{at}ufl.edu
Citation
Cost or revenue: is diabetes prevention doomed due to misalignment of incentives?
Publication history
- Received October 23, 2019
- Revision received December 18, 2019
- Accepted December 20, 2019
- First published January 19, 2020.
Online issue publication
December 20, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.